Haleon Plc publishes 2024 Annual Report

GSK

Haleon plc (LON:HLN) has published its Annual Report and Form 20-F for the year ended 31 December 2024.

The Annual Report is publicly available on the Company’s website at http://www.haleon.com/investors/annual-report-2024.

In compliance with the Disclosure Guidance and Transparency Rules, the Annual Report, as submitted to the National Storage Mechanism, contains regulated information in unedited full text and is available on the Company’s website as noted above.

Shareholders may request a hard copy of the Annual Report, including the complete audited financial statements of the Company. Requests should be directed to: Company Secretariat, Haleon plc, Building 5, First Floor, The Heights, Weybridge, KT13 0NY, United Kingdom or to [email protected].

The Company’s Annual General Meeting (“AGM”) will take place on 28 May 2025. The Notice of AGM will be published and distributed to shareholders in due course.

Share on:
Find more news, interviews, share price & company profile here for:
    Haleon plc releases its Q3 2024 trading update, now available for review. Join the presentation on October 31 for in-depth analysis and insights.
    Haleon plc (NYSE/LON:HLN) impresses with solid Q1 results, showcasing organic revenue growth despite market challenges. Explore key sectors and financial highlights here. #Haleon #ConsumerHealth
    Haleon plc appoints Dawn Allen as Chief Financial Officer, effective 28 October 2024. Tobias Hestler to step down due to health condition.

      Search

      Search